Tekmira Begins Phase I Trial of siRNA Drug for Hypercholesterolemia

According to the company, the trial will evaluate the drug's safety, tolerability, and pharmacokinetics, as well as provide preliminary efficacy data.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.